Select Publications
Book Chapters
1996, 'Immune escape through T cell antagonism?', in Gene Technology, Springer Berlin Heidelberg, pp. 361 - 368, http://dx.doi.org/10.1007/978-3-642-61122-3_26
,Journal articles
2021, 'Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort', AIDS, 35, pp. 2073 - 2084, http://dx.doi.org/10.1097/QAD.0000000000002988
,2019, 'Mapping the drivers of within-host pathogen evolution using massive data sets', Nature Communications, 10, http://dx.doi.org/10.1038/s41467-019-10724-w
,2018, 'Human immunodeficiency virus infection impairs Th1 and Th17 mycobacterium tuberculosis–specific T-Cell responses', Journal of Infectious Diseases, 217, pp. 1782 - 1792, http://dx.doi.org/10.1093/infdis/jiy052
,2016, 'Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection', PLoS Pathogens, 12, http://dx.doi.org/10.1371/journal.ppat.1005661
,2016, 'LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.', J Immunol, 196, pp. 2085 - 2094, http://dx.doi.org/10.4049/jimmunol.1502462
,2016, 'Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency.', Retrovirology, 13, pp. 10, http://dx.doi.org/10.1186/s12977-016-0242-4
,2016, 'TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.', Eur J Immunol, 46, pp. 1600 - 1614, http://dx.doi.org/10.1002/eji.201545969
,2015, 'Immunological biomarkers predict HIV-1 viral rebound after treatment interruption', Nature Communications, 6, pp. 8495, http://dx.doi.org/10.1038/ncomms9495
,2015, 'Structured Observations Reveal Slow HIV-1 CTL Escape', PLoS Genetics, 11, pp. 1 - 22, http://dx.doi.org/10.1371/journal.pgen.1004914
,2015, 'Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study.', Medicine (Baltimore), 94, pp. e1134, http://dx.doi.org/10.1097/MD.0000000000001134
,2014, 'Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, 'definetherain'', Journal of Virological Methods, 202, pp. 46 - 53, http://dx.doi.org/10.1016/j.jviromet.2014.02.020
,2014, 'HIV-1-specific CD4+ responses in primary HIV-1 infection predict disease progression', AIDS, 28, pp. 699 - 708, http://dx.doi.org/10.1097/QAD.0000000000000130
,2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control', eLife, 3, pp. e03821, http://dx.doi.org/10.7554/eLife.03821
,2013, 'Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0078287
,2013, 'Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes', Proceedings of the Royal Society B: Biological Sciences, 280, http://dx.doi.org/10.1098/rspb.2013.0696
,2013, 'Early and nonreversible decrease of CD161++/MAIT cells in HIV infection', Blood, 121, pp. 951 - 961, http://dx.doi.org/10.1182/blood-2012-06-436436
,2013, 'Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection', AIDS, 27, pp. 313 - 323, http://dx.doi.org/10.1097/QAD.0b013e32835b8cf5
,2013, 'Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.', International journal of nanomedicine, 8, pp. 2543 - 2554, http://dx.doi.org/10.2147/ijn.s44013
,2013, 'Short-course antiretroviral therapy in primary HIV infection', New England Journal of Medicine, 368, pp. 207 - 217, http://dx.doi.org/10.1056/NEJMoa1110039
,2012, 'Cytotoxic T-Lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly', Journal of Virology, 86, pp. 8568 - 8580, http://dx.doi.org/10.1128/JVI.07020-11
,2012, 'HIV-2 encephalitis: Case report and literature review', AIDS Patient Care and STDs, 26, pp. 383 - 387, http://dx.doi.org/10.1089/apc.2012.0048
,2012, 'Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection', AIDS, 26, pp. 887 - 890, http://dx.doi.org/10.1097/QAD.0b013e328351e721
,2011, 'Beating atomic swords into immunological ploughshares', Immunity, 35, pp. 10 - 12, http://dx.doi.org/10.1016/j.immuni.2011.07.005
,2011, 'Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants', Retrovirology, 8, http://dx.doi.org/10.1186/1742-4690-8-54
,2011, 'Progression to AIDS in south africa is associated with both reverting and compensatory viral mutations', PLoS ONE, 6, http://dx.doi.org/10.1371/journal.pone.0019018
,2010, 'Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections', Journal of Infectious Diseases, 202, pp. 1482 - 1485, http://dx.doi.org/10.1086/657167
,2010, 'Modelling the evolution and spread of HIV immune escape mutants', PLoS Pathogens, 6, http://dx.doi.org/10.1371/journal.ppat.1001196
,2010, 'Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B*2705-restricted CD8+ T cells', Journal of Virology, 84, pp. 10543 - 10557, http://dx.doi.org/10.1128/JVI.00793-10
,2010, 'B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection', Nature Communications, 1, http://dx.doi.org/10.1038/ncomms1100
,2009, 'Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa', Antiviral Therapy, 14, pp. 975 - 984, http://dx.doi.org/10.3851/IMP1416
,2009, 'No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection', Proceedings of the Royal Society B: Biological Sciences, 276, pp. 4389 - 4397, http://dx.doi.org/10.1098/rspb.2009.1232
,2009, 'Adaptation of HIV-1 to human leukocyte antigen class I', Nature, 458, pp. 641 - 645, http://dx.doi.org/10.1038/nature07746
,2009, 'HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection', Journal of Virology, 83, pp. 1228 - 1239, http://dx.doi.org/10.1128/JVI.01545-08
,2008, 'Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor', Nature Medicine, 14, pp. 1390 - 1395, http://dx.doi.org/10.1038/nm.1779
,2008, 'Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection', Clinical and Experimental Immunology, 152, pp. 532 - 537, http://dx.doi.org/10.1111/j.1365-2249.2008.03653.x
,2008, 'The Staphyloccous aureus eap protein activates expression of proinflammatory cytokines', Infection and Immunity, 76, pp. 2164 - 2168, http://dx.doi.org/10.1128/IAI.01699-07
,2008, 'CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation', Hepatology, 47, pp. 396 - 406, http://dx.doi.org/10.1002/hep.22040
,2008, 'Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation', American Journal of Transplantation, 8, pp. 990 - 999, http://dx.doi.org/10.1111/j.1600-6143.2008.02191.x
,2007, 'Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cells', Infection and Immunity, 75, pp. 5711 - 5715, http://dx.doi.org/10.1128/IAI.00875-07
,2007, 'Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection', PLoS ONE, 2, http://dx.doi.org/10.1371/journal.pone.0000649
,2007, 'Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression', Journal of Virology, 81, pp. 6742 - 6751, http://dx.doi.org/10.1128/JVI.00022-07
,2007, 'Precise identification of a human immunodeficiency virus type 1 antigen processing mutant', Journal of Virology, 81, pp. 2031 - 2038, http://dx.doi.org/10.1128/JVI.00968-06
,2007, 'Erschöpfung der Virus spezifischen CD4+ T-Zellantwort bei der akuten Hepatitis C Infektion', Zeitschrift für Gastroenterologie, 45, http://dx.doi.org/10.1055/s-2007-988473
,2006, 'Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection', Genetics, 174, pp. 1441 - 1453, http://dx.doi.org/10.1534/genetics.105.052019
,2006, 'Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers', European Journal of Immunology, 36, pp. 1847 - 1855, http://dx.doi.org/10.1002/eji.200635886
,2006, 'Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts', Journal of Virology, 80, pp. 7226 - 7234, http://dx.doi.org/10.1128/JVI.02014-05
,2006, 'Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1', BMC Evolutionary Biology, 6, http://dx.doi.org/10.1186/1471-2148-6-28
,2005, 'Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining', Journal of Immunology, 175, pp. 6334 - 6343, http://dx.doi.org/10.4049/jimmunol.175.10.6334
,2005, 'Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants', Journal of Virology, 79, pp. 13953 - 13962, http://dx.doi.org/10.1128/JVI.79.22.13953-13962.2005
,